You are here:Home-Chemical Inhibitors & Agonists-GPCR-Neurokinin Receptor-MLE4901
MLE4901

Chemical Structure : MLE4901

CAS No.: 941690-55-7

MLE4901 (Pavinetant, MLE-4901, AZD-2624, AZD2624)

Catalog No.: PC-61237Not For Human Use, Lab Use Only.

Pavinetant (MLE4901, AZD-2624) is a potent, selective, orally active neurokinin 3 (NK3R) antagonist for the treatment of menopausal hot flushes.

Packing Price Stock Quantity
5 mg $198 In stock
10 mg $298 In stock
25 mg $498 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Pavinetant (MLE4901, AZD-2624) is a potent, selective, orally active neurokinin 3 (NK3R) receptor antagonist for the treatment of menopausal hot flushes.
Pavinetant (MLE4901, AZD-2624) demonstrates drug-like properties with low metabolic turnover rate in vitro and moderate human plasma protein binding.

Physicochemical Properties

M.Wt 459.56
Formula C26H25N3O3S
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(S)-3-(methylsulfonamido)-2-phenyl-N-(1-phenylpropyl)quinoline-4-carboxamide

References

1. Li Y, et al. Xenobiotica. 2010 Nov;40(11):721-9.

2. Skorupskaite K, et al. Neuroendocrinology. 2017 Apr 5. doi: 10.1159/000473893.

3. Prague JK, et al. Lancet. 2017 May 6;389(10081):1809-1820.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: